Lundbeck
HLUN-B.CO
#2798
Rank
โ‚ฌ5.22 B
Marketcap
5,26ย โ‚ฌ
Share price
0.87%
Change (1 day)
1.00%
Change (1 year)
Lundbeck is a Danish pharmaceutical company that produces various pharmaceutical products and has the indications schizophrenia, depression, Parkinson's disease and sleep disorders.

EPS for Lundbeck (HLUN-B.CO)

EPS in 2025 (TTM): 0,54ย โ‚ฌ

According to Lundbeck's latest financial reports the company's current EPS (TTM) is 0,52ย โ‚ฌ. an increase over its 2024 EPS that were of 0,38ย โ‚ฌ.

EPS history for Lundbeck from 2004 to 2025

Annual EPS

Year EPS Change
20250,43ย โ‚ฌ14.5%
20240,38ย โ‚ฌ29.29%
20230,29ย โ‚ฌ23.09%
20220,24ย โ‚ฌ37.26%
20210,17ย โ‚ฌ-84.61%
20201,12ย โ‚ฌ-24.61%
20191,48ย โ‚ฌ-42.06%
20182,56ย โ‚ฌ40.7%
20171,82ย โ‚ฌ146.26%
20160,74ย โ‚ฌ-120.48%
2015-3,60ย โ‚ฌ3231.32%
2014-0,11ย โ‚ฌ-115.78%
20130,69ย โ‚ฌ-23.36%
20120,89ย โ‚ฌ-48.01%
20111,72ย โ‚ฌ-9.68%
20101,90ย โ‚ฌ13.72%
20091,67ย โ‚ฌ24.32%
20081,35ย โ‚ฌ-6.05%
20071,43ย โ‚ฌ81.77%
20060,79ย โ‚ฌ-16.76%
20050,95ย โ‚ฌ-17.58%
20041,15ย โ‚ฌ